Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Mar 31;18(4):1227–1231. doi: 10.1158/1055-9965.EPI-08-0984

Table 2.

Odds Ratio (OR) of Prostate Cancer According to Quintile of Serum Retinol and Stage of Disease Progression at Diagnosis

Serum Retinol
Q11 Q2 Q3 Q4 Q5 p-trend
Cases OR (95% CI)4 Cases OR (95% CI)4 Cases OR (95% CI)4 Cases OR (95% CI)4 Cases OR (95% CI)5

All Cases 2 155 1.00 154 0.97(0.71,1.34) 124 0.77 (0.55,1.07) 130 0.79 (0.57,1.10) 129 0.80 (0.57,1.11) 0.11
Non-Aggressive 3 94 1.00 96 1.22 (0.84,1.79) 71 0.86 (0.58,1.29) 79 0.95 (0.64,1.41) 83 0.97 (0.66,1.43) 0.53
Aggressive 68 1.00 57 0.69 (0.44,1.07) 52 0.64 (0.40,1.00) 49 0.57 (0.36,0.91) 43 0.58 (0.36,0.92) 0.02
Stage III & IV 18 1.00 20 0.87 (0.42,1.79) 19 0.83 (0.40,1.73) 19 0.74 (0.35,1.56) 14 0.69 (0.32,1.51) 0.33
Gleason Sum >=7 66 1.00 48 0.58 (0.37,0.92) 42 0.50 (0.31,0.82) 39 0.45 (0.27,0.73) 39 0.52 (0.32,0.84) 0.01

CI confidence interval

1

Reference category

2

Numbers of Non-Aggressive and Aggressive do not add up to All Cases due to missing information on stage or grade

3

Aggressive defined as Gleason Sum ≥7 or stage III or IV

4

Adjusted for age, time since initial screening, year of blood draw, and study center